Israel’s health ministry on Wednesday cited a “potential link” between the Pfizer-BioNTech vaccine and some cases of mild heart inflammation in young men receiving the vaccine.
the ministry said Statement It concluded that there is “some potential for a possible link” between the second dose of the vaccine and the emergence of myocarditis in men aged 16 to 30 years.
In their research, three teams of experts from the Ministry of Health recorded 275 cases of myocarditis between December 2020 and May 2021, with 148 cases “around the time of vaccination”.
A total of 27 myocarditis cases, including 11 with pre-existing conditions, were reported near the first dose in more than 5.4 million immunizations. This is equivalent to 0.0005 percent of cases arising from the first dose vaccination.
Mild heart swelling was reported in 121 cases within 30 days of taking the second dose, 60 of those with pre-existing conditions. Of the approximately 5.1 million vaccinations, 121 cases are equivalent to 0.002 percent of the second dose.
The ministry said cases usually occur after the second dose, where patients will develop mild illness, chest pain, shortness of breath and rapid heartbeat.
The incidence was mostly reported among young men aged 16 to 19 years, with the link weakening among older populations. Most cases, 95 percent, were considered mild, and patients spent up to four days in the hospital.
Pfizer told The Hill that it was aware of Israel’s research, noting that adverse events “are thoroughly reviewed”, including by Israel’s Ministry of Health.
“No causal link to the vaccine has been established,” the statement said. “With more than 300 million doses of the Pfizer-BioNTech COVID-19 vaccine administered globally, the benefit risk profile of our vaccine remains positive.”
But Dror Mevorach, who led the panel of experts investigating the issue, told science magazine That study is “very suggestive of a casual nature,” and “I believe there is a relationship.”
According to the magazine, Israel has “relyed almost exclusively” on the Pfizer-BioNTech vaccine during its vaccination effort, which has served as a model for other countries for its efficiency.
36 COVID-19 cases and one death were reported in the country in the last day Johns Hopkins Universityhandjob And 56.7 percent of its population has been fully vaccinated.
The Centers for Disease Control and Prevention said in a statement last month that it was seeing “relatively few” cases of myocarditis in young people who have received the vaccine.
Israel is expected to follow the US in requesting the authorization of 12 to 15-year-olds to receive the vaccine, requesting approval from the Director-General of Health. The Food and Drug Administration originally granted emergency authorization for the Pfizer-BioNTech vaccine to people 16 and older.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.